- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic cancer and FOLFIRINOX: a new era and new questions
Authors
Keywords
-
Journal
Cancer Medicine
Volume 4, Issue 6, Pages 853-863
Publisher
Wiley
Online
2015-02-19
DOI
10.1002/cam4.433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study
- (2014) M. Sinn et al. ANNALS OF ONCOLOGY
- Transport properties of pancreatic cancer describe gemcitabine delivery and response
- (2014) Eugene J. Koay et al. JOURNAL OF CLINICAL INVESTIGATION
- Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to theUGT1A1Genotype of Patients With Cancer
- (2014) Federico Innocenti et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic Adenocarcinoma: Treating a Systemic Disease With Systemic Therapy
- (2014) D. P. Sohal et al. JNCI-Journal of the National Cancer Institute
- Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?
- (2014) K. K. Christians et al. ONCOLOGIST
- Hypoxia Triggers Hedgehog-Mediated Tumor-Stromal Interactions in Pancreatic Cancer
- (2013) T. R. Spivak-Kroizman et al. CANCER RESEARCH
- Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated
- (2013) Michael D. Chuong et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity
- (2013) Elizabeth Poplin et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience
- (2013) J. E. Faris et al. ONCOLOGIST
- Complete Pathological Remission of Locally Advanced, Unresectable Pancreatic Cancer (LAPC) after Intensified Neoadjuvant Chemotherapy
- (2013) Ingo Hartlapp et al. ONKOLOGIE
- Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
- (2013) Hemchandra Mahaseth et al. PANCREAS
- Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
- (2013) Uwe Pelzer et al. Frontiers in Oncology
- A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
- (2012) Peter J Hosein et al. BMC CANCER
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
- (2012) Matthew H. G. Katz et al. CANCER
- Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
- (2012) Hiroshi Haeno et al. CELL
- Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical Approaches
- (2012) David A. Tuveson et al. CELL
- Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer
- (2012) Takao Tamura et al. International Journal of Medical Sciences
- Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
- (2012) Sophie Gourgou-Bourgade et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study
- (2012) Jeffrey M. Hardacre et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Acute, generalised but transient muscle cramping and weakness shortly after first oxaliplatin infusion
- (2012) Elisabeth Krexner et al. MEDICAL ONCOLOGY
- Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis
- (2011) Qing Zhao et al. Annals of Diagnostic Pathology
- Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer
- (2011) Yun Shin Chun et al. ANNALS OF SURGICAL ONCOLOGY
- Downstaging Chemotherapy and Alteration in the Classic Computed Tomography/Magnetic Resonance Imaging Signs of Vascular Involvement in Patients With Pancreaticobiliary Malignant Tumors
- (2011) Timothy R. Donahue ARCHIVES OF SURGERY
- Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy
- (2011) Amir Sonnenblick et al. CANCER BIOLOGY & THERAPY
- The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis
- (2011) Hassan K. Dakik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and Survival
- (2011) George J. Arnaoutakis et al. JOURNAL OF GASTROINTESTINAL SURGERY
- The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
- (2011) Nardin Samuel et al. Nature Reviews Gastroenterology & Hepatology
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- 64-Slice CT Perfusion Imaging of Pancreatic Adenocarcinoma and Mass-Forming Chronic Pancreatitis
- (2010) Na Lu et al. ACADEMIC RADIOLOGY
- Treatment of Metachronous and Simultaneous Liver Metastases of Pancreatic Cancer
- (2010) F. Dünschede et al. EUROPEAN SURGICAL RESEARCH
- Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
- (2010) Synne Wedén et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of Splenectomy on Thrombocytopenia, Chemotherapy, and Survival in Patients with Unresectable Pancreatic Cancer
- (2010) Timothy R. Donahue et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy
- (2008) Christopher R. Kauffman et al. CANCER
- A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance
- (2008) Michele Basso et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Douglas B. Evans et al. JOURNAL OF CLINICAL ONCOLOGY
- CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial
- (2008) Viviane Hess et al. LANCET ONCOLOGY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases
- (2007) G. Morris-Stiff et al. EJSO
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started